Lv2
110 积分 2025-01-05 加入
Biologic therapy for psoriasis is associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD). A study on the association of cardiometabolic conditions with psoriasis treatment
2个月前
已完结
Associations of novel complete blood count-derived inflammatory markers with psoriasis: a systematic review and meta-analysis
2个月前
已完结
Evaluation of the inflammatory parameters as potential biomarkers of systemic inflammation extent and the disease severity in psoriasis patients
2个月前
已完结
The risk of malignancy in patients with psoriasis treated with long-term tumour necrosis factor-alpha inhibitors: a systematic review and meta-analysis
2个月前
已完结
Reduced liver disease incidence in psoriasis patients treated with interleukin-23 inhibitors: A longitudinal cohort analysis
2个月前
已完结
Upadacitinib leading to resolution of refractory mucosal erosions in a case of pemphigus vulgaris
5个月前
已完结
Characterization and treatment outcomes of biologic therapy in super-responders and biologic-refractory psoriasis patients: A single-center retrospective study in China
6个月前
已完结
Negative impact of comorbidities on all-cause mortality of patients with psoriasis is partially alleviated by biologic treatment: A real-world case-control study
6个月前
已完结
Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index
6个月前
已完结
Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States
9个月前
已完结
皖公网安备34019202002308
